March 17, 2021

Fresh antitrust push hits biopharma

Evaluate Vantage takes a look at the still-open deals that might come under threat from a new international clampdown.

April 22, 2015

Concerns about soaring generic prices could present Teva with ultimate challenge

January 08, 2015

Buoyant small pharma market hides some big losers

October 06, 2014

Acquisitions help define performance of mid and small cap stocks

September 10, 2014

Interview – Europe endorses Prosonix’s respiratory fix

July 22, 2013

M&A shows signs of recovery

April 04, 2013

Biotech consolidates its dominance in the first quarter

September 28, 2012

Supreme Court could be next up in "pay for delay" saga

April 01, 2011

Valeant's deals and Pfizer's strategy attract admirers in first quarter